Skip to main content
Signal8

Evogene Ltd. Form SCHEDULE 13D/A — Oct 6, 2026

Form SCHEDULE 13D/AFiled Oct 6, 2026, 4:10 PM ET0001213900-26-107207Original filing

L.I.A. Pure Capital, Invest Pro Shukai Hon and their principals (Kfir Silberman and Ron Yair Peled) filed Amendment No. 7 to their Schedule 13D on Evogene Ltd., disclosing a Cooperation Agreement dated October 6, 2026. The group beneficially owns 3,057,488 ordinary shares, approximately 16.94% of the 18,053,071 shares outstanding.

Key figures

Shares Owned
3057488
Standstill days
60
Amendment number
7
Percent of class
16.94%
Shares outstanding
18053071
Invest pro dispositive shares
500000
Invest pro dispositive percent
2.77%
Pure capital dispositive percent
14.17%
Pure capital sole dispositive shares
2557488

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    Evogene Ltd. Form SCHEDULE 13D/A — Oct 6, 2026: AI Analysis | Signal8